Skip to main content

US scientists blocked from Cuba

Officials would not issues licenses for travel to conference on coma and death

Written byLaura Spinney
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00

US scientists intending to travel to Cuba for a conference on coma and death this week were informed five days before the opening ceremony that they would not be permitted to attend.

The bureau that enforces restrictions on travel to Cuba – the Department of the Treasury's Office of Foreign Assets Control (OFAC) – has yet to give its final ruling on the matter, even though the meeting is underway. But last Thursday (March 4) it issued “guidance” that US delegates would most likely not receive authorization for the trip.

Between 75 and 100 US delegates were due to attend the Fourth International Symposium on Coma and Death, which started on 9 March and runs for four days in Havana. US nationals would have accounted for about half the audience.

“This was a high class-scientific conference,” said Stuart Youngner, director of the Center for Biomedical Ethics at Case Western Reserve ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Essential Genes Are Dominantly Activated by Single Transcription Factors

Essential Genes Are Dominantly Activated by Single Transcription Factors

EpiCypher Logo
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays